Explore the full record of transactions filed by 顾美芳, Director. Officer active across 1 companies, notably 昭衍新药. Aggregated, 44 filings have been logged. The latest transaction was disclosed on 30 September 2025 (Sale). Regulator: AMF. All data is accessible without signup.
顾美芳 is a Board Member at昭衍新药. In this role, she participates in the governance of the company and strategic decision-making. Her experience in the pharmaceutical sector is an asset to the management team. 顾美芳 helps define the company's objectives and oversee its development. Her active participation in board meetings is essential to ensure transparency and accountability within昭衍新药.